Osteoarthritis and Bone Disorders News

Tanezumab and NSAIDs both demonstrated early and sustained improvement in pain and function among patients with knee or hip osteoarthritis, according to data published in Arthritis Research and Therapy.

Patients with osteoarthritis who developed dementia were more likely than their counterparts without dementia to be hospitalized for ambulatory care services, according to a speaker at the 2022 OARSI World Congress.

The COVID-19 pandemic has wrecked “significant negative impacts” on pain, function and treatment accessibility for individuals with chronic musculoskeletal pain, according to a speaker at the 2022 OARSI World Congress.

High tibial osteotomy leading to large changes in knee dynamics may reduce the likelihood of total knee replacement in patients with knee osteoarthritis, according to a speaker at the 2022 OARSI World Congress.

Mechanical load plus a biomarker that reflects cartilage degradation may predict worsening cartilage thickness in knee osteoarthritis, according to a speaker at the 2021 OARSI World Congress.

A meta-analysis comparing exercise, opioids and NSAIDs yielded “disappointing” and inconsistent results, in which exercise generally demonstrated some benefit over opioids and NSAIDs, according to a speaker at the 2022 OARSI World Congress.

Patients with hand synovial abnormalities in osteoarthritis demonstrate an abundance of two specific species of gut microbiota, according to findings presented at the 2022 OARSI World Congress.

Evidence showing the positive impact of physical activity on fatigue in symptomatic osteoarthritis is encouraging but limited, according to a speaker at the 2022 OARSI World Congress.

TPX-100, a novel intra-articular injection, yielded strong improvements in bone shape change and function that may ultimately minimize the need for knee replacement, according to a speaker at the 2022 OARSI World Congress.

Increasing rates of walking, standing or maximum-level activity is associated with reductions in cartilage loss in knee osteoarthritis, according to a speaker at the 2022 OARSI World Congress.